FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048854788> ?p ?o ?g. }

• W3048854788 endingPage "384" @default.
• W3048854788 startingPage "369" @default.
• W3048854788 abstract "Abstract Background Randomized controlled trials (RCT) generalizability may be limited due to strict patient selection. Objective In a real‐world heart failure (HF) population, we assessed eligibility for sacubitril/valsartan based on PARADIGM‐HF (sacubitril/valsartan effective)/PARAGON‐HF [sacubitril/valsartan effective in mildly reduced ejection fraction (EF)]. Methods Outpatients from the Swedish HF Registry (SwedeHF) were analysed. In SwedeHF, EF is recorded as <30, 30–39, 40–49 and ≥50%. In PARAGON‐HF, sacubitril/valsartan was effective with EF ≤ 57% (i.e. median). We defined reduced EF/PARADIGM‐HF as EF < 40%, mildly reduced EF/PARAGON‐HF ≤ median as EF 40–49%, and normal EF/PARAGON‐HF > median as EF ≥ 50%. We assessed 2 scenarios: (i) criteria likely to influence treatment decisions (pragmatic scenario); (ii) all criteria (literal scenario). Results Of 37 790 outpatients, 57% had EF < 40%, 24% EF 40–49% and 19% EF ≥ 50%. In the pragmatic scenario, 63% were eligible in EF < 50% (67% for EF < 40% and 52% for 40–49%) and 52% in EF ≥ 40% (52% for EF ≥ 50%). For the literal scenario, 32% were eligible in EF < 50% (38% of EF < 40%, 20% of EF 40–49%) and 22% in EF ≥ 40% (25% for EF ≥ 50%). Eligible vs. noneligible patients had more severe HF, more comorbidities and overall worse outcomes. Conclusion In a real‐world HF outpatient cohort, 81% of patients had EF < 50%, with 63% eligible for sacubitril/valsartan based on pragmatic criteria and 32% eligible based on literal trial criteria. Similar eligibility was observed for EF 40–49% and ≥50%, suggesting that our estimates for EF < 50% may be reproduced whether or not a higher cut‐off for EF is considered." @default.
• W3048854788 created "2020-08-18" @default.
• W3048854788 creator A5015344056 @default.
• W3048854788 creator A5031285642 @default.
• W3048854788 creator A5042030729 @default.
• W3048854788 creator A5046116651 @default.
• W3048854788 creator A5047360772 @default.
• W3048854788 creator A5062149714 @default.
• W3048854788 creator A5067972379 @default.
• W3048854788 creator A5068884647 @default.
• W3048854788 creator A5078817987 @default.
• W3048854788 creator A5079136466 @default.
• W3048854788 creator A5084443221 @default.
• W3048854788 date "2020-09-01" @default.
• W3048854788 modified "2023-10-16" @default.
• W3048854788 title "Eligibility for sacubitril/valsartan in heart failure across the ejection fraction spectrum: real‐world data from the Swedish Heart Failure Registry" @default.
• W3048854788 cites W1988719573 @default.
• W3048854788 cites W2098418963 @default.
• W3048854788 cites W2113698123 @default.
• W3048854788 cites W2281894904 @default.
• W3048854788 cites W2427094903 @default.
• W3048854788 cites W2590976410 @default.
• W3048854788 cites W2649240144 @default.
• W3048854788 cites W2758197294 @default.
• W3048854788 cites W2790962299 @default.
• W3048854788 cites W2799433946 @default.
• W3048854788 cites W2886031306 @default.
• W3048854788 cites W2899841238 @default.
• W3048854788 cites W2923219557 @default.
• W3048854788 cites W2947681783 @default.
• W3048854788 cites W2947972779 @default.
• W3048854788 cites W2964077523 @default.
• W3048854788 cites W2971294569 @default.
• W3048854788 cites W2980734809 @default.
• W3048854788 cites W2989425857 @default.
• W3048854788 doi "https://doi.org/10.1111/joim.13165" @default.
• W3048854788 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7984286" @default.
• W3048854788 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32776357" @default.
• W3048854788 hasPublicationYear "2020" @default.
• W3048854788 type Work @default.
• W3048854788 sameAs 3048854788 @default.
• W3048854788 citedByCount "9" @default.
• W3048854788 countsByYear W30488547882021 @default.
• W3048854788 countsByYear W30488547882022 @default.
• W3048854788 countsByYear W30488547882023 @default.
• W3048854788 crossrefType "journal-article" @default.
• W3048854788 hasAuthorship W3048854788A5015344056 @default.
• W3048854788 hasAuthorship W3048854788A5031285642 @default.
• W3048854788 hasAuthorship W3048854788A5042030729 @default.
• W3048854788 hasAuthorship W3048854788A5046116651 @default.
• W3048854788 hasAuthorship W3048854788A5047360772 @default.
• W3048854788 hasAuthorship W3048854788A5062149714 @default.
• W3048854788 hasAuthorship W3048854788A5067972379 @default.
• W3048854788 hasAuthorship W3048854788A5068884647 @default.
• W3048854788 hasAuthorship W3048854788A5078817987 @default.
• W3048854788 hasAuthorship W3048854788A5079136466 @default.
• W3048854788 hasAuthorship W3048854788A5084443221 @default.
• W3048854788 hasBestOaLocation W30488547881 @default.
• W3048854788 hasConcept C126322002 @default.
• W3048854788 hasConcept C164705383 @default.
• W3048854788 hasConcept C2775999527 @default.
• W3048854788 hasConcept C2776754050 @default.
• W3048854788 hasConcept C2777387769 @default.
• W3048854788 hasConcept C2778198053 @default.
• W3048854788 hasConcept C2908647359 @default.
• W3048854788 hasConcept C71924100 @default.
• W3048854788 hasConcept C72563966 @default.
• W3048854788 hasConcept C78085059 @default.
• W3048854788 hasConcept C84393581 @default.
• W3048854788 hasConcept C99454951 @default.
• W3048854788 hasConceptScore W3048854788C126322002 @default.
• W3048854788 hasConceptScore W3048854788C164705383 @default.
• W3048854788 hasConceptScore W3048854788C2775999527 @default.
• W3048854788 hasConceptScore W3048854788C2776754050 @default.
• W3048854788 hasConceptScore W3048854788C2777387769 @default.
• W3048854788 hasConceptScore W3048854788C2778198053 @default.
• W3048854788 hasConceptScore W3048854788C2908647359 @default.
• W3048854788 hasConceptScore W3048854788C71924100 @default.
• W3048854788 hasConceptScore W3048854788C72563966 @default.
• W3048854788 hasConceptScore W3048854788C78085059 @default.
• W3048854788 hasConceptScore W3048854788C84393581 @default.
• W3048854788 hasConceptScore W3048854788C99454951 @default.
• W3048854788 hasFunder F4320307778 @default.
• W3048854788 hasFunder F4320322169 @default.
• W3048854788 hasFunder F4320322581 @default.
• W3048854788 hasIssue "3" @default.
• W3048854788 hasLocation W30488547881 @default.
• W3048854788 hasLocation W30488547882 @default.
• W3048854788 hasLocation W30488547883 @default.
• W3048854788 hasLocation W30488547884 @default.
• W3048854788 hasOpenAccess W3048854788 @default.
• W3048854788 hasPrimaryLocation W30488547881 @default.
• W3048854788 hasRelatedWork W2758753471 @default.
• W3048854788 hasRelatedWork W2776335933 @default.
• W3048854788 hasRelatedWork W2904992990 @default.
• W3048854788 hasRelatedWork W2914028752 @default.
• W3048854788 hasRelatedWork W2969131214 @default.
• W3048854788 hasRelatedWork W3188325112 @default.

• next